ANVS
Price
$1.71
Change
+$0.01 (+0.59%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
33.13M
91 days until earnings call
KYTX
Price
$2.12
Change
-$0.20 (-8.62%)
Updated
May 14, 04:59 PM (EDT)
Capitalization
100.27M
Ad is loading...

ANVS vs KYTX

Header iconANVS vs KYTX Comparison
Open Charts ANVS vs KYTXBanner chart's image
Annovis Bio
Price$1.71
Change+$0.01 (+0.59%)
Volume$292
Capitalization33.13M
Kyverna Therapeutics
Price$2.12
Change-$0.20 (-8.62%)
Volume$17.19K
Capitalization100.27M
ANVS vs KYTX Comparison Chart
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. KYTX commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a StrongBuy and KYTX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (ANVS: $1.70 vs. KYTX: $2.32)
Brand notoriety: ANVS and KYTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 130% vs. KYTX: 133%
Market capitalization -- ANVS: $33.13M vs. KYTX: $100.27M
ANVS [@Biotechnology] is valued at $33.13M. KYTX’s [@Biotechnology] market capitalization is $100.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 0 FA rating(s) are green whileKYTX’s FA Score has 0 green FA rating(s).

  • ANVS’s FA Score: 0 green, 5 red.
  • KYTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ANVS is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 7 TA indicator(s) are bullish while KYTX’s TA Score has 5 bullish TA indicator(s).

  • ANVS’s TA Score: 7 bullish, 3 bearish.
  • KYTX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than KYTX.

Price Growth

ANVS (@Biotechnology) experienced а +18.06% price change this week, while KYTX (@Biotechnology) price change was +15.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.95%. For the same industry, the average monthly price growth was +6.81%, and the average quarterly price growth was -5.99%.

Reported Earning Dates

ANVS is expected to report earnings on Aug 13, 2025.

KYTX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+0.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($100M) has a higher market cap than ANVS($33.1M). KYTX YTD gains are higher at: -37.968 vs. ANVS (-66.203). ANVS has higher annual earnings (EBITDA): -26.69M vs. KYTX (-108.46M). KYTX has more cash in the bank: 322M vs. ANVS (10.6M). ANVS (0) and KYTX (0) have equivalent revenues.
ANVSKYTXANVS / KYTX
Capitalization33.1M100M33%
EBITDA-26.69M-108.46M25%
Gain YTD-66.203-37.968174%
P/E RatioN/AN/A-
Revenue00-
Total Cash10.6M322M3%
Total DebtN/A9.14M-
TECHNICAL ANALYSIS
Technical Analysis
ANVSKYTX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+9.68%
ADXN - ANVS
43%
Loosely correlated
+0.12%
EWTX - ANVS
33%
Poorly correlated
+0.47%
PRME - ANVS
29%
Poorly correlated
-5.22%
TNYA - ANVS
29%
Poorly correlated
-4.06%
KYTX - ANVS
29%
Poorly correlated
+4.98%
More

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with CABA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
+4.98%
CABA - KYTX
47%
Loosely correlated
+2.33%
IMNM - KYTX
44%
Loosely correlated
-0.38%
CRSP - KYTX
44%
Loosely correlated
-0.98%
TRDA - KYTX
41%
Loosely correlated
-1.36%
PRME - KYTX
41%
Loosely correlated
-5.22%
More